425 related articles for article (PubMed ID: 18471934)
21. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Williams A; Piaton G; Aigrot MS; Belhadi A; Théaudin M; Petermann F; Thomas JL; Zalc B; Lubetzki C
Brain; 2007 Oct; 130(Pt 10):2554-65. PubMed ID: 17855378
[TBL] [Abstract][Full Text] [Related]
22. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
23. CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.
Omari KM; John GR; Sealfon SC; Raine CS
Brain; 2005 May; 128(Pt 5):1003-15. PubMed ID: 15774504
[TBL] [Abstract][Full Text] [Related]
24. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
[TBL] [Abstract][Full Text] [Related]
25. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo.
Butt AM; Dinsdale J
Exp Neurol; 2005 Mar; 192(1):125-33. PubMed ID: 15698626
[TBL] [Abstract][Full Text] [Related]
27. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
28. Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats.
O'Leary MT; Hinks GL; Charlton HM; Franklin RJ
Mol Cell Neurosci; 2002 Jan; 19(1):32-42. PubMed ID: 11817896
[TBL] [Abstract][Full Text] [Related]
29. Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination.
Niehaus A; Shi J; Grzenkowski M; Diers-Fenger M; Archelos J; Hartung HP; Toyka K; Brück W; Trotter J
Ann Neurol; 2000 Sep; 48(3):362-71. PubMed ID: 10976643
[TBL] [Abstract][Full Text] [Related]
30. Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination.
Capello E; Voskuhl RR; McFarland HF; Raine CS
Ann Neurol; 1997 Jun; 41(6):797-805. PubMed ID: 9189041
[TBL] [Abstract][Full Text] [Related]
31. Remyelination can be extensive in multiple sclerosis despite a long disease course.
Patani R; Balaratnam M; Vora A; Reynolds R
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):277-87. PubMed ID: 17442065
[TBL] [Abstract][Full Text] [Related]
32. A recombinant human IgM promotes myelin repair after a single, very low dose.
Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
[TBL] [Abstract][Full Text] [Related]
33. Involvement of insulin-like growth factor binding protein-2 in activated microglia as assessed in post mortem human brain.
Chesik D; De Keyser J; Wilczak N
Neurosci Lett; 2004 May; 362(1):14-6. PubMed ID: 15147770
[TBL] [Abstract][Full Text] [Related]
34. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
Freude S; Leeser U; Müller M; Hettich MM; Udelhoven M; Schilbach K; Tobe K; Kadowaki T; Köhler C; Schröder H; Krone W; Brüning JC; Schubert M
J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
[TBL] [Abstract][Full Text] [Related]
35. Oligodendrocytes and the early multiple sclerosis lesion.
Prineas JW; Parratt JD
Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
[TBL] [Abstract][Full Text] [Related]
36. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis.
Höftberger R; Fink S; Aboul-Enein F; Botond G; Olah J; Berki T; Ovadi J; Lassmann H; Budka H; Kovacs GG
Glia; 2010 Nov; 58(15):1847-57. PubMed ID: 20737479
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
38. Cortical remyelination: a new target for repair therapies in multiple sclerosis.
Chang A; Staugaitis SM; Dutta R; Batt CE; Easley KE; Chomyk AM; Yong VW; Fox RJ; Kidd GJ; Trapp BD
Ann Neurol; 2012 Dec; 72(6):918-26. PubMed ID: 23076662
[TBL] [Abstract][Full Text] [Related]
39. Distribution of components of the insulin-like growth factor system in the temporomandibular joint of the aging mouse.
Götz W; Dühr S; Jäger A
Growth Dev Aging; 2005; 69(2):67-79. PubMed ID: 16671586
[TBL] [Abstract][Full Text] [Related]
40. Remyelination in demyelinating disease.
Scolding NJ; Franklin RJ
Baillieres Clin Neurol; 1997 Oct; 6(3):525-48. PubMed ID: 10101588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
